Home/Filings/4/0000899243-23-006016
4//SEC Filing

Duckworth David M. 4

Accession 0000899243-23-006016

CIK 0001520697other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 5:17 PM ET

Size

8.1 KB

Accession

0000899243-23-006016

Insider Transaction Report

Form 4
Period: 2023-02-21
Duckworth David M.
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2023-02-21+195,248294,511 total
  • Award

    Common Stock

    2023-02-21+6,803301,314 total
  • Tax Payment

    Common Stock

    2023-02-21$80.87/sh76,830$6,213,242224,484 total
Footnotes (2)
  • [F1]Shares received upon vesting of performance vesting restricted stock units awarded on March 24, 2020.
  • [F2]Shares earned based on 2022 performance under performance vesting restricted stock units awarded on April 11, 2022. The shares will not be issued until the end of the three-year period under the restricted stock unit award.

Issuer

Acadia Healthcare Company, Inc.

CIK 0001520697

Entity typeother

Related Parties

1
  • filerCIK 0001555047

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:17 PM ET
Size
8.1 KB